These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 23643808

  • 1. Alteration of prolyl oligopeptidase and activated α-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome.
    Tenorio-Laranga J, Peltonen I, Keskitalo S, Duran-Torres G, Natarajan R, Männistö PT, Nurmi A, Vartiainen N, Airas L, Elovaara I, García-Horsman JA.
    Biochem Pharmacol; 2013 Jun 15; 85(12):1783-94. PubMed ID: 23643808
    [Abstract] [Full Text] [Related]

  • 2. Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression.
    Teunissen CE, Sombekke M, van Winsen L, Killestein J, Barkhof F, Polman CH, Dijkstra CD, Blankenstein MA, Pratico D.
    Mult Scler; 2012 Aug 15; 18(8):1092-8. PubMed ID: 22695538
    [Abstract] [Full Text] [Related]

  • 3. Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis.
    Avsar T, Korkmaz D, Tütüncü M, Demirci NO, Saip S, Kamasak M, Siva A, Turanli ET.
    Mult Scler; 2012 Aug 15; 18(8):1081-91. PubMed ID: 22252467
    [Abstract] [Full Text] [Related]

  • 4. IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis.
    Frisullo G, Nociti V, Iorio R, Patanella AK, Marti A, Caggiula M, Mirabella M, Tonali PA, Batocchi AP.
    Cytokine; 2008 Oct 15; 44(1):22-5. PubMed ID: 18793860
    [Abstract] [Full Text] [Related]

  • 5. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review.
    Karussis D.
    J Autoimmun; 2014 Oct 15; 48-49():134-42. PubMed ID: 24524923
    [Abstract] [Full Text] [Related]

  • 6. Cytokine profile, Foxp3 and nuclear factor-kB ligand levels in multiple sclerosis subtypes.
    Alatab S, Maghbooli Z, Hossein-Nezhad A, Khosrofar M, Mokhtari F.
    Minerva Med; 2011 Dec 15; 102(6):461-8. PubMed ID: 22193377
    [Abstract] [Full Text] [Related]

  • 7. Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases.
    Brettschneider J, Jaskowski TD, Tumani H, Abdul S, Husebye D, Seraj H, Hill HR, Fire E, Spector L, Yarden J, Dotan N, Rose JW.
    J Neuroimmunol; 2009 Dec 10; 217(1-2):95-101. PubMed ID: 19879655
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis.
    Antonelou RCh, Emmanouilidou E, Gasparinatos G, Velona T, Voumvourakis KI, Stefanis L.
    J Neurochem; 2015 Aug 10; 134(4):748-55. PubMed ID: 25962981
    [Abstract] [Full Text] [Related]

  • 12. Increased cerebrospinal fluid chitotriosidase index in patients with multiple sclerosis.
    Verbeek MM, Notting EA, Faas B, Claessens-Linskens R, Jongen PJ.
    Acta Neurol Scand; 2010 May 10; 121(5):309-14. PubMed ID: 19925532
    [Abstract] [Full Text] [Related]

  • 13. Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis.
    Simpson S, Taylor B, Dwyer DE, Taylor J, Blizzard L, Ponsonby AL, Pittas F, Dwyer T, van der Mei I.
    Mult Scler; 2012 Jun 10; 18(6):799-806. PubMed ID: 22084489
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Elevated HSP27 levels during attacks in patients with multiple sclerosis.
    Ce P, Erkizan O, Gedizlioglu M.
    Acta Neurol Scand; 2011 Nov 10; 124(5):317-20. PubMed ID: 21208199
    [Abstract] [Full Text] [Related]

  • 17. Antinuclear and antiphospholipid antibodies in patients with multiple sclerosis.
    Szmyrka-Kaczmarek M, Pokryszko-Dragan A, Pawlik B, Gruszka E, Korman L, Podemski R, Wiland P, Szechinski J.
    Lupus; 2012 Apr 10; 21(4):412-20. PubMed ID: 22074845
    [Abstract] [Full Text] [Related]

  • 18. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
    Venken K, Hellings N, Hensen K, Rummens JL, Medaer R, D'hooghe MB, Dubois B, Raus J, Stinissen P.
    J Neurosci Res; 2006 Jun 10; 83(8):1432-46. PubMed ID: 16583400
    [Abstract] [Full Text] [Related]

  • 19. Potential role of OPG/RANKL system and FokI genotypes in pathogenesis and clinical manifestations in multiple sclerosis.
    Mirzaei K, Ahmadi S, Hossein-Nezhad A, Mokhtari F.
    Minerva Med; 2012 Aug 10; 103(4):313-21. PubMed ID: 22805623
    [Abstract] [Full Text] [Related]

  • 20. Proteomic pattern analysis discriminates among multiple sclerosis-related disorders.
    Komori M, Matsuyama Y, Nirasawa T, Thiele H, Becker M, Alexandrov T, Saida T, Tanaka M, Matsuo H, Tomimoto H, Takahashi R, Tashiro K, Ikegawa M, Kondo T.
    Ann Neurol; 2012 May 10; 71(5):614-23. PubMed ID: 22522477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.